Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
General Internal Medicine
•
Neurology
When would you consider using vigabatrin as part of treatment for status epilepticus?
Related Questions
How do you utilize at-home seizure monitoring devices for your patients with epilepsy?
How do you adjust the management of epilepsy in patients who are planning to fast?
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
When, if ever, would you pursue genetic testing in an asymptomatic child with multiple first-degree relatives with epilepsy?
How do you manage follow-up lab findings of hyperchloremic metabolic acidosis and low bicarbonate in patients on zonisamide or topiramate?
When do you need to keep patients on anti-seizure medications when they had an acute symptomatic seizure in the setting of eclampsia, particularly if MgSO4 was given and there was no seizure recurrence?
What is your approach to weaning phenobarbital and serial EEGs in patients with HIE after their perinatal seizures are under control?
What prompts you to procure EEG and/or imaging in patients presenting with multiple simple febrile seizures?
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
